prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FINAL DIAGNOSIS: PART 1: AXILLARY SENTINEL NODE #1, RIGHT, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 2: BREAST, RIGHT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION 3, NUCLEAR GRADE 2,. MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). B. THE TUMOR SIZE MEASURES 1.8 CM IN GREATEST DIMENSION (GROSS MEASUREMENT). C. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM AND SOLID TYPES. D. DCIS CONSTITUTES 15% OF TOTAL TUMOR VOLUME, MIXED AND AWAY FROM THE INVASIVE. COMPONENT. E. SURGICAL MARGINS ARE NEGATIVE FOR CARCINOMA; INVASIVE TUMOR IS 7 MM TO THE CLOSEST. ANTERIOR MARGIN, AND DCIS IS 7 MM TO THE POSTERIOR MARGIN. F. NO LYMPHOVASCULAR INVASION NOTED. G. FOCI OF MICROCALCIFICATIONS ASSOCIATED WITH INVASIVE CARCINOMA, DCIS, AND BENIGN BREAST. TISSUE. H. NON-NEOPLASTIC BREAST TISSUE SHOWING FIBROCYSTIC CHANGES, DUCTAL EPITHELIAL. HYPERPLASIA, COLUMNAR CELL CHANGE, AND SCLEROSING ADENOSIS. I. BIOPSY SITE CHANGES. J. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ER/PR AND NEGATIVE FOR HER-2/NEU. PART 3: BREAST, ANTERIOR MARGIN, RIGHT, BIOPSY -. A. BREAST TISSUE WITH FIBROCYSTIC CHANGE, NEGATIVE FOR CARCINOMA. B. ENTIRE TISSUE SUBMITTED FOR MICROSCOPIC EXAMINATION. PART 4: BREAST, MEDIALIPOSTERIOR MARGIN, RIGHT, BIOPSY. A. BREAST TISSUE WITH FIBROCYSTIC CHANGE, DUCTAL EPITHELIAL HYPERPLASIA AND SCLEROSING. ADENOSIS. B. ENTIRE SPECIMEN SUBMITTED FOR MICROSCOPIC EXAMINATION. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. ANGIOL IMPRATIC INVASION: DERIMAL EXMPHATIC INVASION: Not applicable. CALE. ALION: Yes, benign zones. Yes, malignant zones. INVOLVED BY INVASIVE COMPONENT: ED: 1. ODE EXAMINATION: H/E stain, Keratin stain. pT1c. pMX. RS: positive. CEPTORS: positive. zero or 1+.

expanded version (tokens=1035) : 
 Histological classification: 
- Invasive Ductal Carcinoma (IDC)
- Ductal Carcinoma in Situ (DCIS)

Subtype: LumA 

Description of any necrosis: None mentioned.

Mention of tumor infiltrating lymphocytes: No tumor infiltrating lymphocytes noted.

Histological grade: Nottingham Grade 2 (Tubule formation 3, Nuclear grade 2, Mitotic activity 1; Total score 6/9).

Nuclear grade: 2 

Lymphovascular invasion: No lymphovascular invasion noted.

Calcification: Foci of microcalcifications associated with invasive carcinoma, DCIS, and benign breast tissue.

Receptor status: ER/PR positive, HER-2/neu negative.

Ancillary testing:
- Keratin stain
- Synoptic report shows pT1c and pMX, RS is positive, receptor status is positive with zero or 1+.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1221) : 
 LumA subtype ductal carcinoma in situ (DCIS) and invasive ductal carcinoma detected. Nottingham grade 2. No necrosis or lymphovascular invasion noted. Foci of calcification found with benign and malignant tissue. ER/PR positive, HER-2/neu negative via ancillary testing. Biopsy site changes present, with non-neoplastic breast tissue showing ductal epithelial hyperplasia and fibrocystic changes. Surgical margins negative for cancer. Surgical procedure was a segmental mastectomy with a maximum tumor dimension of 1.8 cm, with no evidence of metastatic carcinoma found in one lymph node tested during the axillary sentinel node biopsy.

